468.40
+7.75
+(1.68%)
At close: January 10 at 3:30:02 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
7,667,538.00
7,696,562.00
6,797,546.00
7,130,224.00
4,876,987.00
Cost of Revenue
3,842,157.00
3,992,924.00
3,409,039.00
4,228,168.00
2,555,067.00
Gross Profit
3,825,381.00
3,703,638.00
3,388,507.00
2,902,056.00
2,321,920.00
Operating Expense
2,522,484.00
2,392,102.00
2,235,198.00
1,611,058.00
1,640,440.00
Operating Income
1,302,897.00
1,311,536.00
1,153,309.00
1,290,998.00
681,480.00
Net Non Operating Interest Income Expense
-152,167.00
-139,478.00
-68,113.00
-34,866.00
-121,828.00
Pretax Income
1,140,349.00
1,156,715.00
1,067,209.00
1,268,383.00
577,115.00
Tax Provision
291,077.00
295,359.00
270,161.00
309,982.00
134,799.00
Net Income Common Stockholders
849,279.00
861,356.00
797,048.00
958,401.00
442,316.00
Diluted NI Available to Com Stockholders
849,279.00
861,356.00
797,048.00
958,401.00
442,316.00
Basic EPS
8.47
8.74
8.22
9.89
4.56
Diluted EPS
8.47
8.74
8.22
9.89
4.56
Basic Average Shares
100,179.49
98,519.94
96,944.51
96,944.51
96,944.51
Diluted Average Shares
100,179.49
98,519.94
96,944.51
96,944.51
96,944.51
Rent Expense Supplemental
--
14,700.00
13,368.00
23,910.00
10,444.00
Total Expenses
6,364,641.00
6,385,026.00
5,644,237.00
5,839,226.00
4,195,507.00
Net Income from Continuing & Discontinued Operation
849,279.00
861,356.00
797,048.00
958,401.00
442,316.00
Normalized Income
866,404.47
878,480.38
796,822.45
957,884.16
442,029.36
Interest Income
--
14,121.00
14,120.00
18,792.00
14,505.00
Interest Expense
158,326.00
145,637.00
66,357.00
40,064.00
117,657.00
Net Interest Income
-152,167.00
-139,478.00
-68,113.00
-34,866.00
-121,828.00
EBIT
1,298,675.00
1,302,352.00
1,133,566.00
1,308,447.00
694,772.00
EBITDA
1,469,543.00
1,472,524.00
1,356,377.00
1,497,737.00
857,848.00
Reconciled Cost of Revenue
3,842,157.00
3,992,924.00
3,409,039.00
4,228,168.00
2,555,067.00
Reconciled Depreciation
170,868.00
170,172.00
222,811.00
189,290.00
163,076.00
Net Income from Continuing Operation Net Minority Interest
849,279.00
861,356.00
797,048.00
958,401.00
442,316.00
Total Unusual Items Excluding Goodwill
-22,995.00
-22,995.00
302.00
684.00
374.00
Total Unusual Items
-22,995.00
-22,995.00
302.00
684.00
374.00
Normalized EBITDA
1,492,538.00
1,495,519.00
1,356,075.00
1,497,053.00
857,474.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-5,869.53
-5,870.62
76.45
167.16
87.36
3/31/2021 - 10/19/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INDOCO.NS Indoco Remedies Limited
327.80
-1.90%
THEMISMED.NS Themis Medicare Limited
260.65
-3.91%
AMRUTANJAN.NS Amrutanjan Health Care Limited
702.45
-1.11%
RPGLIFE.NS RPG Life Sciences Limited
2,112.25
-4.40%
WINDLAS.NS Windlas Biotech Limited
988.75
-2.69%
JBCHEPHARM.NS J. B. Chemicals & Pharmaceuticals Limited
1,823.05
-2.53%
HIKAL.NS Hikal Limited
358.05
-3.66%
AARTIPHARM.NS Aarti Pharmalabs Limited
669.50
+1.42%
NOVARTIND.BO Novartis India Limited
879.60
-3.76%
SAKAR.NS Sakar Healthcare Limited
294.55
-0.05%